Vanguard Global Advisers »

Ocular Therapeutix shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $601k 71k 8.47

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Ocular Therapeutix

FMR
Deep Track Capital
BlackRock
Summer Road
Vanguard Group
venBio Select Advisor
VR Adviser
Vanguard Capital Management
Point72 Asset Management
Adage Capital Partners GP
Geode Capital Management
State Street Corporation
Alliancebernstein
Logos Global Management
Octagon Capital Advisors

View all funds holding Ocular Therapeutix